Carnot Pasteur MS

The Carnot Institute Pasteur Microbes et Santé

By developing research applications and transferring technological solutions to industry, the institut Carnot Pasteur Microbes et Santé is able to respond to global public health challenges. 
As a major player in research on infectious and chronic diseases, the institut Carnot Pasteur Microbes et Santé aims to promote, with industry partners, the development of innovative products in therapeutics, diagnostics, vaccines and biotechnology fields.

Economic sectors

Pharmaceuticals
Health technologies
Key figures
Fermer

Key figures

Permanent staff (full-time equivalent)
762
PhD Students
169
Global budget
95 M€
Partnership
incomes with industry
15 M€
Contact
Fermer

Contact

Pasteur MS Carnot Institute
25-28 rue du Docteur Roux
75724 Paris Cedex 15
France

Jean-Christophe OLIVO-MARIN
+ 33 (0)1 45 68 85 06

Email contact
Parent institutions
Fermer

Parent institutions


Presentation

Accelerate the time-to-market of therapeutic, diagnostic, vaccine and biotechnological solutions

Interdisciplinarity and integrative approach

The action of the institut Carnot Pasteur Microbes et Santé is structured around 4 themes, of which each forms a continuum between fundamental, applied and translational research: emerging infectious diseases; antimicrobial resistance; microbiota and non-communicable diseases; interface with maths, physics and chemistry. 
Infectious diseases are a major industrial and public health issue, and remain in the core actions carried out by the institut Carnot Pasteur Microbes et Santé. 
Its scope consists of six Institut Pasteur departments that primarily deal with infectious diseases (Cell Biology and Infection, Global Health, Microbiology, Parasites and Insect Vectors, Virology and Mycology), in association with several immunology, neuroscience, structural biology and chemistry units. 
Interdisciplinarity is key to finding new therapeutic and diagnostic strategies, particularly for diseases involving the immune system (chronic infection, autoimmune diseases) or of neurodegenerative and cerebral origin (Alzheimer's and Parkinson's in particular). 

Target markets

  • Diagnostic tests
  • Vaccines
  • Anti-infectives
  • Medical biotechnology
  • Innovative medical devices
  • Technologies for life sciences
  • Artificial intelligence
  • Innovations in the food industry
  • Probiotics
  • Alicaments

State-of-the-art technologies

Innovative technologies applied to biology, such as chemogenomic screening, imaging and microfluidics, are sources of innovation that open up new perspectives in biomedical research, in particular the identification of new biomarkers or therapeutic targets. This is why several units and technological platforms are also part of the institut Carnot Pasteur Microbes et Santé.

Promoting the development of new inventions into products

Accelerating innovation

Integrated into the institut Carnot Pasteur Microbes et Santé, the Institut Pasteur's Accelerator of Innovation supports various projects with high potential and valuable assets for transfer to industry. By combining funding strategies, technical support and business expertise, the Accelerator of Innovation aims to reduce technological development times in terms of licensing and commercialization of scientific discoveries.

What we offer to our industrial partners:

  • Extended and transversal diversity of R&D fields based on the Institut Pasteur’s expertise 
  • Joint application to national and international calls for proposals (IMI, H2020, NIH, CEPI, etc.)
  • Companies with R&D activity in France are also eligible for 60% research tax credit
  • Easy access to scientific and technological expertise and several platforms open to companies 
  • Institut Pasteur grants exploitation rights

Bringing together academic and industrial researchers 

  • By creating mixed laboratories and industrial chairs, the institut Carnot Pasteur Microbes et Santé wishes to encourage the co-development of innovative ideas.
  • The CIFRE scheme (Industrial Agreements for Training Through Research) also aims to support the development of public-private partnership research by co-financing the training of a doctoral student recruited by a private company. Every year, the institut Carnot Pasteur Microbes et Santé supports the training of several PhD students within the framework of joint research projects.